disease-modifying osteoarthritis drug (DMOAD)

Polysulfated glycosaminoglycan (PSGAG) inhibits the action of enzyme that destroy degenerative / traumatic cartilage 

Stimulate collagen production

• Non infectious degenerative / traumatic arthritis of canine synovial joints
• Restore joint lubrication 
• Relive inflammation and renew the foundation of healthy cartilage 

• 2mg/lb bwt
• Twice weekly upto 4 weeks
• Maximum 8 injection (IM)

Kidney impairment

Bleeding abnormality

Delayed blood clotting

Pain at site of injection

Adequan canine

• 5 ml vial
• Each ml contains 100mg